Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | CA12 | O43570 | 1/20 | 0.54 |
| ▸ | CA1 | P00915 | 1/20 | 0.54 |
| ▸ | CA2 | P00918 | 1/20 | 0.54 |
| ▸ | CA7 | P43166 | 1/20 | 0.54 |
| ▸ | CA9 | Q16790 | 1/20 | 0.54 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.51 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | MAOB | P27338 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5695937 | 0.88 | TDP1 (0.67) | TDP1KMT2AALDH1A1CA12CA1 | |
| SCHEMBL14363401 | 0.87 | TDP1 (0.60) | TDP1KMT2AMEN1ALDH1A1SLC6A2 | |
| SCHEMBL28557117 | 0.86 | KMT2A (0.59) | TDP1KMT2AMEN1ALDH1A1SLC6A2 | |
| SCHEMBL4758455 | 0.86 | TDP1 (0.73) | TDP1KMT2AMEN1ALDH1A1CA12 | |
| SCHEMBL7511115 | 0.85 | KMT2A (0.62) | TDP1KMT2AMEN1ALDH1A1CA12 | |
| SCHEMBL10783794 | 0.85 | ALDH1A1 (0.69) | TDP1KMT2AALDH1A1SLC6A2SLC6A3 | |
| Hydrochloric Acid SCHEMBL30842846 | 0.85 | KMT2A (0.58) | TDP1KMT2AMEN1ALDH1A1SLC6A2 | |
| SCHEMBL10787402 | 0.85 | ALDH1A1 (0.69) | TDP1KMT2AALDH1A1SLC6A2SLC6A3 | |
| SCHEMBL15341181 | 0.84 | TDP1 (0.74) | TDP1KMT2AALDH1A1SLC6A2SLC6A3 | |
| SCHEMBL22519217 | 0.84 | DHODH (0.56) | TDP1KMT2AALDH1A1KDM4ESLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6458757-B1 | PROCESS FOR THE PRODUCTION OF PERFUMING COMPOSITIONS, PERFUMED PRODUCTS AND SUBSTANCES FOR PERFUMERY CHARACTERIZED IN THAT THEY COMPRISE, AS AN ACTIVE INGREDIENT WITH AN INFLUENCE ON THE SCENT, AN EFFECTIVE QUANTITY OF AN ALKYLSALICYLIC ACID | Chimie, Rhodia (FR) | 2002-10-01 | — | — | US | claimed |
| EP-0876325-B1 | METHOD FOR PREPARING SCENTING COMPOSITIONS AND SCENTED PRODUCTS, AND RESULTING PRODUCTS | RHODIA CHIMIE SA (FR) | 2002-01-09 | — | — | EP | claimed |
| US-20170246193-A1 | FATTY ACID ACETYLATED SALICYLATES AND THEIR USES | CATABASIS PHARMACEUTICALS, INC. | 2017-08-31 | — | — | US | disclosed |
| US-9458094-B2 | Fatty acid acetylated salicylates and their uses | CATABASIS PHARMACEUTICALS, INC. (US) | 2016-10-04 | — | — | US | disclosed |
| WO-2016116603-A1 | NOVEL PHENYLPHOSPHATES AND USE THEREOF AS MEDICAMENTS | UNIVERSITÄT LEIPZIG (DE) | 2016-07-28 | — | — | WO | disclosed |
| US-9272984-B2 | Fatty acid acetylated salicylates and their uses | CATABASIS PHARMACEUTICALS, INC. (US) | 2016-03-01 | — | — | US | disclosed |
| US-9139516-B2 | Fatty acid acetylated salicylates and their uses | CATABASIS PHARMACEUTICALS, INC. (US) | 2015-09-22 | — | — | US | disclosed |
| US-20150099723-A1 | FATTY ACID ACETYLATED SALICYLATES AND THEIR USES | CATABASIS PHARMACEUTICALS, INC. (US) | 2015-04-09 | — | — | US | disclosed |
| US-20140221323-A1 | FATTY ACID ACETYLATED SALICYLATES AND THEIR USES | CATABASIS PHARMACEUTICALS, INC. (US) | 2014-08-07 | — | — | US | disclosed |
| US-8735378-B2 | Fatty acid acetylated salicylates and their uses | CATABASIS PHARMACEUTICALS, INC. (US) | 2014-05-27 | — | — | US | disclosed |
| US-8729293-B2 | Fatty acid acetylated salicylates and their uses | CATABASIS PHARMACEUTICALS, INC. (US) | 2014-05-20 | — | — | US | disclosed |
| US-20120238586-A1 | FATTY ACID ACETYLATED SALICYLATES AND THEIR USES | CATABASIS PHARMACEUTICALS, INC. (US) | 2012-09-20 | — | — | US | disclosed |
| US-20040127737-A1 | Process for the preparation of carboxylic acid benzyl esters | BAYER AKTIENGESELLSCHAFT (DE) | 2004-07-01 | — | — | US | disclosed |
| US-20030233008-A1 | Process for the preparation of carboxylic benzyl esters | BAYER AKTIENGESELLSCHAFT (DE) | 2003-12-18 | — | — | US | disclosed |
| US-6639093-B2 | Reacting benzyl chloride with hydroxybenzoic acid | BAYER AKTIENGESELLSCHAFT (DE) | 2003-10-28 | — | — | US | disclosed |
| US-6600064-B2 | Reacting dibenzyl ethers with alkylcarbonyloxybenzoic or alkoxycarbonyloxybenzoic acids in the presence of one or more acids as catalyst | BAYER AKTIENGESELLSCHAFT (DE) | 2003-07-29 | — | — | US | disclosed |
| US-20030053964-A1 | Process for the preparation of hydroxybenzoic benzyl esters | BAYER AKTIENGESELLSCHAFT (DE) | 2003-03-20 | — | — | US | disclosed |
| US-20030055279-A1 | Process for the preparation of benzyl carboxylates | BAYER AKTIENGESELLSCHAFT (DE) | 2003-03-20 | — | — | US | disclosed |
| US-6458757-B1 | PROCESS FOR THE PRODUCTION OF PERFUMING COMPOSITIONS, PERFUMED PRODUCTS AND SUBSTANCES FOR PERFUMERY CHARACTERIZED IN THAT THEY COMPRISE, AS AN ACTIVE INGREDIENT WITH AN INFLUENCE ON THE SCENT, AN EFFECTIVE QUANTITY OF AN ALKYLSALICYLIC ACID | Chimie, Rhodia (FR) | 2002-10-01 | — | — | US | disclosed |
| US-20020128523-A1 | Process for the preparation of hydroxybenzoic benzyl esters | LANXESS DEUTSCHLAND GMBH (DE) | 2002-09-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040127737-A1 | Process for the preparation of carboxylic acid benzyl esters | CA4, CA7, CA9 | TDP1 4705/4885KMT2A 820/4885MEN1 2911/4885 |
| US-20030233008-A1 | Process for the preparation of carboxylic benzyl esters | CPS1, BCAT2, BCAT1 | TDP1 4251/4885KMT2A 1295/4885MEN1 3278/4885 |
| US-20150099723-A1 | FATTY ACID ACETYLATED SALICYLATES AND THEIR USES | FASN, ACACA, FABP4 | TDP1 4524/4885KMT2A 1744/4885MEN1 4861/4885 |
| US-20030055279-A1 | Process for the preparation of benzyl carboxylates | GABRG2, CA4, NBAS | TDP1 4546/4885KMT2A 1281/4885MEN1 3545/4885 |
| US-20120238586-A1 | FATTY ACID ACETYLATED SALICYLATES AND THEIR USES | FASN, ACACA, FABP4 | TDP1 4524/4885KMT2A 1744/4885MEN1 4861/4885 |
| US-20170246193-A1 | FATTY ACID ACETYLATED SALICYLATES AND THEIR USES | FASN, ACACA, FABP4 | TDP1 4524/4885KMT2A 1744/4885MEN1 4861/4885 |
| US-20140221323-A1 | FATTY ACID ACETYLATED SALICYLATES AND THEIR USES | FASN, ACACA, FABP4 | TDP1 4524/4885KMT2A 1744/4885MEN1 4861/4885 |
| US-20030053964-A1 | Process for the preparation of hydroxybenzoic benzyl esters | HAAO, HPD, HACL2 | TDP1 3956/4885KMT2A 690/4885MEN1 3925/4885 |
| US-20020128523-A1 | Process for the preparation of hydroxybenzoic benzyl esters | HAAO, HPD, ALKBH3 | TDP1 3355/4885KMT2A 513/4885MEN1 3487/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.